Mylan EpiPen Antitrust Class Action Lawsuit

The settlement benefits individuals and entities who paid for or provided reimbursement for branded EpiPens or generic equivalents between Aug. 24, 2011, and Nov. 1, 2020. You may be eligible for a potential award from the Mylan EpiPen Antitrust Class Action Lawsuit!

According to the class action, Mylan may have worked with Pfizer to artificially raise the price of life saving EpiPen products. The plaintiffs claim the companies knowingly violated antitrust and racketeering laws through their scheme. Instead, the company allegedly distributed the data among third-party cloud servers. So if you are eligible, file a claim by June 25, 2022 to receive your potential award!

Table of Contents

Mylan EpiPen Antitrust CAL

Claim Form Deadline: June 25, 2022
Who’s Eligible: The settlement benefits individuals and entities who paid for or provided reimbursement for branded EpiPens or generic equivalents between Aug. 24, 2011, and Nov. 1, 2020.
Estimated Amount: Varies
Proof of Purchase: You do not need to provide any documentation at this time. However, the Settlement Administrator may ask for additional proof supporting your claim.
Case Name & Number: In re: EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation, Civil Action No. 2:17-md-02785-DDC-TJJ, in the U.S. District Court for the District of Kansas

File a Claim

(Click here to file a claim)

How To File a Claim

Head over to the Mylan EpiPen Antitrust Claim Form.
Read over the claim form to see if you are eligible.
Complete the claim form with your info.
Submit your claim form to receive your potential award by June 25, 2022!

Bottom Line

If you are eligible, file a claim by the deadline to receive your potential award! Don’t forget to take a look at our full list of Class Action Lawsuit Settlements! Be sure to give our list of No-Proof Class Action lawsuit to see other settlements you may qualify for.